BOSTON SCIENTIFIC CORP【BSX】Income statement

Market cap

$144.5B

P/E ratio

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	7,806	7,622	7,249	7,143	7,380	7,477	8,386	9,048	9,823	10,735	9,913	11,888	12,682	14,240	16,747
Revenue growth (%)	-
Cost of revenue	2,599	2,659	2,349	2,174	2,210	2,173	2,424	2,593	2,813	3,116	3,465	3,711	3,956	4,345	5,257
Gross profit	5,207	4,963	4,900	4,969	5,170	5,304	5,962	6,455	7,011	7,620	6,448	8,177	8,727	9,896	11,490
Gross margin (%)
Selling, general & administrative	2,580	2,487	2,535	2,674	2,902	2,873	3,099	3,294	3,569	3,941	3,787	4,359	4,520	5,190	5,984
Operating margin (%)
Operating income	-656	904	-3,868	120	-301	-327	447	1,285	1,506	1,518	-80	1,199	1,649	2,343	2,603
Operating expenses	5,863	4,059	8,768	4,849	5,471	5,631	5,515	5,170	5,504	6,102	6,528	6,978	7,078	7,553	8,887
Income before tax	-	642	-4,107	-223	-509	-650	177	933	1,422	687	-79	1,076	1,141	1,985	2,282
Pretax margin (%)	-	8.4	-56.7	-3.1	-6.9	-8.7	2.1	10.3	14.5	6.4	-0.8	9.1	9	13.9	13.6
Provision for income taxes	2	201	-39	-102	-390	-411	-170	828	-249	-4,013	2	36	443	393	436
Effective tax rate (%)	-
Net income	-1,065	441	-4,068	-121	-119	-239	347	104	1,671	4,700	-82	1,041	698	1,592	1,846
Net income margin (%)
Earnings per share	-0.7	0.29	-2.89	-0.09	-0.09	-0.18	0.26	0.08	1.21	3.38	-0.08	0.69	0.45	1.08	1.26
Diluted EPS	-0.7	0.29	-2.89	-0.09	-0.09	-0.18	0.25	0.08	1.19	3.33	-0.08	0.69	0.45	1.07	1.25
EBITDA	-
EBITDA margin (%)	-